Stay updated with breaking news from String Technologies. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Leading researchers in breast and pancreatic cancer share first insights utilizing the GeoMx Immuno-oncology Proteome Atlas ...
NanoString Technologies (NASDAQ:NSTG – Free Report) had its price target lowered by UBS Group from $7.00 to $2.50 in a research report report published on Thursday, Benzinga reports. UBS Group currently has a buy rating on the biotechnology company’s stock. NSTG has been the topic of a number of other reports. Canaccord Genuity Group reaffirmed […]
- Record Q3 Revenue of Over $48 Million, 63% Year on Year Growth, Above Upper End of Q3 Guidance Range - - Implementing Reorganization of R&D and Manufacturing Operations to Improve Path to...
StockNews.com assumed coverage on shares of NanoString Technologies (NASDAQ:NSTG – Free Report) in a report published on Thursday. The firm issued a sell rating on the biotechnology company’s stock. Several other research firms also recently issued reports on NSTG. Canaccord Genuity Group reaffirmed a buy rating and set a $10.00 price objective on shares of […]
A*STAR’s Genome Institute of Singapore , NanoString® Technologies, Inc. , and Next Level Genomics , today announced the establishment of a joint laboratory in Singapore focusing on the application...